Beperidium iodide

• UNSPSC Description:

  Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.

• Target Antigen:

  mAChR

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein;Neuronal Signaling

• Applications:

  COVID-19-immunoregulation

• Field of Research:

  Inflammation/Immunology

• Assay Protocol:

  https://www.medchemexpress.com/Beperidium_iodide.html

• Purity:

  99.79

• Solubility:

  DMSO : ≥ 100 mg/mL

• Smiles:

  C[N+]1(CC)CCC(OC(C(C2=NOC3=C2C=CC=C3)N4CCCCCC4)=O)CC1.[I-]

• Molecular Weight:

  527.44

• References & Citations:

  [1]Kawashima K, et al. Pharmacological properties of the novel antimuscarinic agent 4-[2-(1,2-benzisoxazol-3-yl)-2-(hexahydro-1H-azepin-1-yl)a cetoxy]-1-et hyl-1- methylpiperidinium iodide. Arzneimittelforschung. 1986 Jun;36(6):927-35.

• Shipping Conditions:

  Room Temperature

• Storage Conditions:

  4°C (Powder, sealed storage, away from moisture and light)

• Clinical Information:

  No Development Reported

• CAS Number:

  86434-57-3